Short Interest in Matinas BioPharma Holdings Inc (MTNB) Rises By 1.8%
Matinas BioPharma Holdings Inc (NYSE:MTNB) saw a large growth in short interest in August. As of August 31st, there was short interest totalling 2,609,755 shares, a growth of 1.8% from the August 15th total of 2,564,755 shares. Based on an average trading volume of 112,526 shares, the short-interest ratio is currently 23.2 days. Approximately 3.9% of the company’s stock are sold short.
Matinas BioPharma Holdings (MTNB) opened at 1.25 on Friday. The firm’s market cap is $114.97 million. The firm’s 50-day moving average is $1.29 and its 200 day moving average is $2.28. Matinas BioPharma Holdings has a 12-month low of $1.01 and a 12-month high of $3.99.
ILLEGAL ACTIVITY NOTICE: “Short Interest in Matinas BioPharma Holdings Inc (MTNB) Rises By 1.8%” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/16/short-interest-in-matinas-biopharma-holdings-inc-mtnb-rises-by-1-8.html.
Matinas BioPharma Holdings Company Profile
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections.
Receive News & Ratings for Matinas BioPharma Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.